Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months

TOVO, Pier Angelo;
2010-01-01

2010
15
3
297
305
http://www.intmedpress.com/serveFile.cfm?sUID=56c28f1a-7cf1-4339-8c4b-25475ead3313
Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Infant; RNA, Viral; Treatment Outcome; Anti-HIV Agents; Dideoxynucleosides; Lamivudine; Reverse Transcriptase Inhibitors; Pharmacology; Pharmacology (medical); Infectious Diseases; Medicine (all)
Paediatric European Network for Treatment of AIDS (PENTA) including Jacqz-Aigrain E; Harrison L; Zhao W; Compagnucci A; Castro H; Farrelly L; Saidi Y;...espandi
File in questo prodotto:
File Dimensione Formato  
antivirther.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 680.7 kB
Formato Adobe PDF
680.7 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1594923
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 25
social impact